Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Robert L St Claire"'
Autor:
Eve-Irene Lepist, Hunter Gillies, William Smith, Jia Hao, Cassandra Hubert, Robert L St Claire, Kenneth R Brouwer, Adrian S Ray
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87548 (2014)
Inhibition of the transporter-mediated hepatobiliary elimination of bile salts is a putative mechanism for liver toxicity observed with some endothelin receptor antagonists (ERAs).Sandwich-cultured human hepatocytes were used to study the hepatobilia
Externí odkaz:
https://doaj.org/article/c42eeeca463f467d81ac31d4e10c3353
Publikováno v:
Drug Metabolism and Pharmacokinetics. 35:S60-S61
Autor:
William J. Brock, Robert L. St. Claire, Yang Lu, Jason R. Slizgi, Maxwell Pan, Kenneth R. Brouwer, Kimberly M. Freeman, Kim L. R. Brouwer
Publikováno v:
Drug Metabolism and Disposition. 44:867-870
Tolvaptan is a selective V2-receptor antagonist primarily metabolized by CYP 3A. The present study investigated the hepatocellular disposition of tolvaptan and the generated tolvaptan metabolites, DM-4103 and DM-4107, as well as the potential for dru
Autor:
Kim L. R. Brouwer, Robert L. St. Claire, Jeffrey L. Woodhead, Paul B. Watkins, Cen Guo, Scott Q. Siler, Kyunghee Yang, Brett A. Howell
Publikováno v:
Journal of Pharmaceutical Sciences. 105:443-459
Sandwich-cultured hepatocytes (SCH) are metabolically competent and have proper localization of basolateral and canalicular transporters with functional bile networks. Therefore, this cellular model is a unique tool that can be used to estimate bilia
Autor:
Robert L. St. Claire, Kimberly M. Freeman, Kim L. R. Brouwer, Jason R. Slizgi, William J. Brock, Yang Lu, Maxwell Pan, Kenneth R. Brouwer
Publikováno v:
Toxicological Sciences. 149:237-250
Tolvaptan is a vasopressin V(2)-receptor antagonist that has shown promise in treating Autosomal Dominant Polycystic Kidney Disease (ADPKD). Tolvaptan was, however, associated with liver injury in some ADPKD patients. Inhibition of bile acid transpor
Transporter-mediated alterations in bile acid disposition may have significant toxicological implications. Current methods to predict interactions are limited by the interplay of multiple transporters, absence of protein in the experimental system, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d21e1a7a2b1264608c14a4e620363db0
https://europepmc.org/articles/PMC4959093/
https://europepmc.org/articles/PMC4959093/
Autor:
Robert L. St. Claire, Jonathan P. Jackson, Christopher B. Black, Kenneth R. Brouwer, Matthew K. Palmer, Kimberly Freeman
Publikováno v:
Drug Metabolism and Pharmacokinetics. 33:S71
Autor:
Kimberly Freeman, Matthew K. Palmer, Kenneth R. Brouwer, Jonathan P. Jackson, Robert L. St. Claire, Christopher B. Black
Publikováno v:
Drug Metabolism and Pharmacokinetics. 33:S72
Autor:
Cassandra H. Perry, William R. Smith, Robert L. St. Claire, John H. Ansede, Kenneth R. Brouwer
Publikováno v:
Drug Metabolism and Disposition. 38:276-280
Drug-induced cholestasis can result from the inhibition of biliary efflux of bile acids in the liver. Drugs may inhibit the hepatic uptake and/or the biliary efflux of bile acids resulting in an increase in serum concentrations. However, it is the in
Autor:
John A. Begley, Jeanette Harris, Franck Rousseau, Charles Wakeford, Laurene H. Wang, Robert L. St. Claire
Publikováno v:
AIDS Research and Human Retroviruses. 20:1173-1182
Emtricitabine (FTC) is a potent deoxycytidine nucleoside analogue that was recently approved for the treatment of HIV infection. Emtricitabine is activated by intracellular phosphorylation to its 5'-triphosphate (FTC5'-TP), a competitive inhibitor of